{"disease":{"id":"diseases-of-the-nervous-system","name":"diseases of the nervous system"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT05154370","title":"China National Registry of Neuro-Inflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05414890","title":"Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05415579","title":"Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Dongzhimen Hospital, Beijing","has_results":false},{"nct_id":"NCT04672590","title":"COVID-19 Neurological Disease: A Prospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":1017,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT04762342","title":"Power Training in Older Multiple Sclerosis Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04539002","title":"Aerobic Exercise for Remyelination in Multiple Sclerosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT04837651","title":"Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Dragonfly Research, LLC","has_results":false},{"nct_id":"NCT04561557","title":"Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06677710","title":"IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":34,"lead_sponsor_name":"Indapta Therapeutics, INC.","has_results":false},{"nct_id":"NCT05414487","title":"Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05214612","title":"Predictors and Prognostic Factors of Myasthenia Gravis Outcome","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05792176","title":"Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT03540485","title":"Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT04786821","title":"Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT06797024","title":"JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Tongji Hospital","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}